{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:12:55Z","timestamp":1790230375536,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":4296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1093\/annonc\/mdm543","type":"journal-article","created":{"date-parts":[[2007,12,4]],"date-time":"2007-12-04T01:59:28Z","timestamp":1196733568000},"page":"570-576","source":"Crossref","is-referenced-by-count":80,"title":["The impact of follicular lymphoma on health-related quality of life"],"prefix":"10.1016","volume":"19","author":[{"given":"R.","family":"Pettengell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Donatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Poynton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Kettle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.S.","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Rule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm543_bb0010","first-page":"213","article-title":"Follicular lymphoma: expanding therapeutic options","volume":"19","author":"Ganti","year":"2005","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdm543_bb0015","author":"ISD Online","year":"2005","journal-title":"Cancer Incidence, Mortality and Survival Data"},{"key":"10.1093\/annonc\/mdm543_bb0020","unstructured":"Northern Ireland Cancer Registry. Cancer Registrations in Northern Ireland 2002 http:\/\/www.qub.ac.uk\/research-centres\/nicr\/Data\/OnlineStatistics\/Non-HodgkinsLymphoma\/. (21 November 2007, date last accessed)"},{"key":"10.1093\/annonc\/mdm543_bb0025","unstructured":"Office for National Statistics. Cancer Statistics Registrations of Cancer Diagnosed in 2002(Series MB1 no. 33). http:\/\/www.statistics.gov.uk\/ (21 November 2007, date last accessed)"},{"key":"10.1093\/annonc\/mdm543_bb0030","unstructured":"Welsh Cancer Intelligence and Surveillance UnitCancer Registrations in Wales 2002 http:\/\/www.wales.nhs.uk\/ (21 November 2007, date last accessed)"},{"key":"10.1093\/annonc\/mdm543_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics","volume":"49","author":"Parkin","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1093\/annonc\/mdm543_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6030","article-title":"Rituximab as third-line treatment for refractory or recurrent stage III or IV follicular non-Hodgkin's lymphoma: a systematic review","volume":"6","author":"Wake","year":"2002","journal-title":"Health Technol Assess"},{"key":"10.1093\/annonc\/mdm543_bb0045","unstructured":"National Comprehensive Cancer NetworkNon-Hodgkin's Lymphoma: Treatment Guidelines for Patients. Version I\/October 2003 http:\/\/www.cancer.org\/docroot\/STT\/content\/STT_1x_Cancer_Facts__Figures_2007.asp\/ (21 November 2007, date last accessed)"},{"key":"10.1093\/annonc\/mdm543_bb0050","first-page":"697","article-title":"Quality of life in patients with low-grade non-Hodgkin's lymphoma","volume":"12","author":"Webster","year":"1998","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdm543_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08964289.1990.9934587","article-title":"Cancer recurrence as a traumatic event","volume":"16","author":"Cella","year":"1990","journal-title":"Behav Med"},{"key":"10.1093\/annonc\/mdm543_bb0060","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1634\/theoncologist.7-3-217","article-title":"Progress and promise in the treatment of indolent lymphomas","volume":"7","author":"McLaughlin","year":"2002","journal-title":"Oncologist"},{"key":"10.1093\/annonc\/mdm543_bb0065","first-page":"714","article-title":"The Webster\/Cella article reviewed","volume":"12","author":"Basen-Engquist","year":"2002","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdm543_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2354.1994.tb00029.x","article-title":"Beyond cancer: changes, problems and needs expressed by adult lymphoma survivors attending an out-patients clinic","volume":"3","author":"Wallwork","year":"1994","journal-title":"Eur J Cancer Care"},{"issue":"9","key":"10.1093\/annonc\/mdm543_bb0075","first-page":"1495","article-title":"Development and multilingual validation of the FACT-LYM","volume":"13","author":"Eremenco","year":"2004","journal-title":"Presented at ISOQOL Annual Conference. 17th October 2004. Qual Life Res"},{"key":"10.1093\/annonc\/mdm543_bb0080","first-page":"2103","article-title":"Measuring quality of life (QOL) in patients with non-hodgkin's lymphoma (NHL): the Functional Assessment of Cancer Therapy-Lymphoma (FACT-LYM)","volume":"14","author":"Webster","year":"2005","journal-title":"Qual Life Res"},{"key":"10.1093\/annonc\/mdm543_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1093\/annonc\/mdm543_bb0090","series-title":"The Hospital Anxiety and Depression Scale: Manual London, UK:","author":"Snaith","year":"1994"},{"key":"10.1093\/annonc\/mdm543_bb0095","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1093\/annonc\/mdm543_bb0100","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0277-9536(82)90210-6","article-title":"Anomic aspects of recovery from cancer","volume":"16","author":"Maher","year":"1982","journal-title":"Soc Sci Med"},{"key":"10.1093\/annonc\/mdm543_bb0105","first-page":"719","article-title":"The cost of treating relapsed indolent non-Hodgkin's lymphoma in an international setting; retrospective analysis of resource use","volume":"87","author":"Herold","year":"2002","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdm543_bb0110","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm543_bb0115","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","article-title":"Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin's lymphoma, both in patients with and without rituximab during induction: results of a prospective randomized phase III intergroup trial","volume":"108","author":"van Oers","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm543_bb0120","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2003-02-0622","article-title":"High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis","volume":"102","author":"Gopal","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm543_bb0125","volume":"104","author":"Schilder","year":"2004","journal-title":"Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin(R)) induces long-term responses in patients with relapsed or refractory follicular lymphoma (FL)"},{"key":"10.1093\/annonc\/mdm543_bb0130","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.2003.10.023","article-title":"High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial","volume":"21","author":"Schouten","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm543_bb0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419411873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419411873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/3\/570\/686085\/mdm543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T09:57:00Z","timestamp":1624442220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419411873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0923753419411873"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm543","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}